Key role of the RhoA/Rho kinase system in pulmonary hypertension

Michelle J. Connolly, Philip I. Aaronson

    Research output: Contribution to journalLiterature reviewpeer-review

    57 Citations (Scopus)

    Abstract

    Pulmonary hypertension (PH) is a general term comprising a spectrum of pulmonary hypertensive disorders which have in common an elevation of mean pulmonary arterial pressure (mPAP). The prototypical form of the disease, termed pulmonary arterial hypertension (PAH), is a rare but lethal syndrome with a complex aetiology characterised by increased pulmonary vascular resistance (PVR) and progressive elevation of mPAP; patients generally die from heart failure. Current therapies are inadequate and median survival is less than three years. PH due to chronic hypoxia (CH) is a condition separate from PAH and is strongly associated with chronic obstructive pulmonary disease (COPD). An early event in the pathogenesis of this form of PH is hypoxic pulmonary vasoconstriction (HPV), an acute homeostatic process that maintains the ventilation-perfusion ratio during alveolar hypoxia. The mechanisms underlying HPV remain controversial, but RhoA/Rho kinase (ROK)-mediated Ca2+-sensitisation is considered important. Increasing evidence also implicates RhoA/ROK in PASMC proliferation, inflammatory cell recruitment and the regulation of cell motility, all of which are involved in the pulmonary vascular remodelling occurring in all forms of PH. ROK is therefore a potential therapeutic target in treating PH of various aetiologies. Here, we examine current concepts regarding the aetiology of PAH and also PH due to CH, focusing on the contribution that RhoA/ROK-mediated processes may make to their development and on ROK inhibitors as potential therapies. (C) 2010 Elsevier Ltd. All rights reserved.
    Original languageEnglish
    Pages (from-to)1 - 14
    Number of pages14
    JournalPULMONARY PHARMACOLOGY AND THERAPEUTICS
    Volume24
    Issue number1
    DOIs
    Publication statusPublished - Feb 2011

    Fingerprint

    Dive into the research topics of 'Key role of the RhoA/Rho kinase system in pulmonary hypertension'. Together they form a unique fingerprint.

    Cite this